双嘧达莫与华法林用于人工心脏瓣膜置换患者：双盲试验 - Suppr | 超能文献

[Dipyridamole and warfarin in patients with artificial heart valve prosthesis: double-blind tests].

作者信息

Ciavarella N, Antoncecchi S, D'Elia N

出版信息

Cardiologia. 1985 Apr;30(4):301-7.

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

[Dipyridamole and warfarin in patients with artificial heart valve prosthesis: double-blind tests].双嘧达莫与华法林用于人工心脏瓣膜置换患者：双盲试验

Cardiologia. 1985 Apr;30(4):301-7.

2

Platelet inhibitors in the treatment of thrombosis.

Clin Invest Med. 1978;1(3-4):191-206.

3

Use of Persantine in preventing thromboembolism following valve replacement.

Am Surg. 1972 Aug;38(8):432-5.

4

Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.抗血小板药物与风湿性心脏病患者中圣犹达医疗主动脉瓣膜假体血栓栓塞并发症的发生率

J Thorac Cardiovasc Surg. 1986 Jan;91(1):92-8.

5

Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.双嘧达莫-阿司匹林用于人工主动脉瓣置换术后患者的血栓栓塞预防。对型号为2320的斯塔尔-爱德华兹人工瓣膜进行的前瞻性研究。

J Thorac Cardiovasc Surg. 1981 Apr;81(4):632-5.

6

Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).

N Engl J Med. 1975 Dec 4;293(23):1174-8. doi: 10.1056/NEJM197512042932305.

7

Pharmacologic control of thromboembolic complications of cardiac-valve replacement.

N Engl J Med. 1971 Jun 24;284(25):1391-4. doi: 10.1056/NEJM197106242842501.

8

Dipyridamole combined with anticoagulant in prevention of early postoperative thromboembolism after cardiac valve replacement.双嘧达莫联合抗凝剂预防心脏瓣膜置换术后早期血栓栓塞

Thromb Res Suppl. 1990;12:27-33. doi: 10.1016/0049-3848(90)90436-g.

9

[Drug-induced modification of thrombocyte turnover in patients with artificial heart valves].[人工心脏瓣膜患者中药物诱导的血小板周转率改变]

Schweiz Med Wochenschr. 1974 Jan 26;104(4):142-4.

10

Failure of sulphinpyrazone to affect platelet survival in patients with rheumatic heart valvular disease: a double blind study using 75Se-methionine labeled platelets.磺吡酮对风湿性心脏瓣膜病患者血小板存活的影响：一项使用75硒-蛋氨酸标记血小板的双盲研究。

Folia Haematol Int Mag Klin Morphol Blutforsch. 1983;110(4):594-601.

引用本文的文献

1

Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.颅内出血中抗栓药物逆转指南：神经重症监护学会和危重症医学会给医疗保健专业人员的声明

Neurocrit Care. 2016 Feb;24(1):6-46. doi: 10.1007/s12028-015-0222-x.

2

Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery.心脏或胸外科手术患者静脉血栓栓塞的一级预防

Cochrane Database Syst Rev. 2015 Jun 19;2015(6):CD009658. doi: 10.1002/14651858.CD009658.pub2.

3

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.抗血小板治疗随机试验的协作综述——I：各类患者长期抗血小板治疗预防死亡、心肌梗死和中风。抗血小板试验协作组。

BMJ. 1994 Jan 8;308(6921):81-106.